Showing results (1-10 of 883) with videos related to
Sort By:
Pageof 89
Journal of Hypertension|August 4, 2015
Angiotensin receptor blockers are not associated with reduced inflammatory markers in the general populationPedro Marques-Vidal, Peter Vollenweider, Gérard WaeberDiabetes Care|June 4, 2011
Estimating the risk of developing type 2 diabetes: a comparison of several risk scores: the Cohorte Lausannoise studyRémy Schmid, Peter Vollenweider, Gérard Waeber, et al.Atherosclerosis|August 23, 2011
Association of statins with inflammatory cytokines: a population-based Colaus studyTanica Lyngdoh, Peter Vollenweider, Gérard Waeber, et al.BMC Pharmacology & Toxicology|April 2, 2014
Antihypertensive drug treatment changes in the general population: the CoLaus studyVanessa Christe, Gérard Waeber, Peter Vollenweider, et al.Cytokine|March 6, 2014
Cytokines and hs-CRP levels in individuals treated with low-dose aspirin for cardiovascular prevention: a population-based study (CoLaus Study)Julien Vaucher, Pedro Marques-Vidal, Gérard Waeber, et al.International Journal of Cardiology|August 14, 2012
Who is at low risk for cardiovascular disease? An assessment of different definitionsAntoine Gabioud, Gérard Waeber, Peter Vollenweider, et al.Journal of Patient Safety|March 14, 2020
Ten-Year Trend in Polypharmacy in the Lausanne PopulationNazanin Abolhassani, Peter Vollenweider, Gérard Waeber, et al.BMC Public Health|April 18, 2015
Prevalence of measured and reported multimorbidity in a representative sample of the Swiss populationBasile Pache, Peter Vollenweider, Gérard Waeber, et al.European Journal of Preventive Cardiology|April 12, 2018
Population impact of the 2017 ACC/AHA guidelines compared with the 2013 ESH/ESC guidelines for hypertension managementJulien Vaucher, Pedro Marques-Vidal, Gérard Waeber, et al.Pageof 89